Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James F Morley

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|September 3, 2022
Selected autonomic signs and symptoms as risk markers for phenoconversion and functional dependence in prodromal Parkinson's diseaseCameron Miller-Patterson, Jesse Y Hsu, Lana M Chahine, et al.
Journal of Geriatric Psychiatry and Neurology|May 30, 2025
Physical Activity, Patient-Reported Outcomes, and Quality of Life in Parkinson's DiseaseJames F Morley, Indu Subramanian, Joshua Farahnik, et al.
Movement Disorders Clinical Practice|October 27, 2018
Olfactory Impairment Predicts Underlying Dopaminergic Deficit in Presumed Drug-Induced ParkinsonismJames F Morley, Gang Cheng, Jacob G Dubroff, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 26, 2011
Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's diseaseJames F Morley, Daniel Weintraub, Eugenia Mamikonyan, et al.
Movement Disorders Clinical Practice|September 13, 2021
Commentary: Uremic Striatopallidal Syndrome Manifesting as Acute Onset ChoreaAnthony E Lang, Emily Forbes, Pavan A Vaswani, et al.
NPJ Parkinson'S Disease|April 28, 2022
Gait abnormalities and non-motor symptoms predict abnormal dopaminergic imaging in presumed drug-induced ParkinsonismWhitley W Aamodt, Jacob G Dubroff, Gang Cheng, et al.
Movement Disorders Clinical Practice|October 27, 2018
Memantine and Cognition in Parkinson's Disease Dementia/Dementia With Lewy Bodies: A Meta-AnalysisLaura Brennan, Alexander Pantelyat, John E Duda, et al.
Neurology|November 16, 2012
Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson diseaseJoshua M Milber, Joseph V Noorigian, James F Morley, et al.
Neurology. Clinical Practice|June 28, 2016
High patient satisfaction with telehealth in Parkinson disease: A randomized controlled studyJayne R Wilkinson, Meredith Spindler, Stephanie M Wood, et al.
Archives of Rehabilitation Research and Clinical Translation|March 27, 2023
Deploying Digital Health Technologies for Remote Physical Activity Monitoring of Rural Populations With Chronic Neurologic DiseaseKimberly J Waddell, Mitesh S Patel, Jayne R Wilkinson, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|September 3, 2022
Selected autonomic signs and symptoms as risk markers for phenoconversion and functional dependence in prodromal Parkinson's diseaseCameron Miller-Patterson, Jesse Y Hsu, Lana M Chahine, et al.
Journal of Geriatric Psychiatry and Neurology|May 30, 2025
Physical Activity, Patient-Reported Outcomes, and Quality of Life in Parkinson's DiseaseJames F Morley, Indu Subramanian, Joshua Farahnik, et al.
Movement Disorders Clinical Practice|October 27, 2018
Olfactory Impairment Predicts Underlying Dopaminergic Deficit in Presumed Drug-Induced ParkinsonismJames F Morley, Gang Cheng, Jacob G Dubroff, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 26, 2011
Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's diseaseJames F Morley, Daniel Weintraub, Eugenia Mamikonyan, et al.
Movement Disorders Clinical Practice|September 13, 2021
Commentary: Uremic Striatopallidal Syndrome Manifesting as Acute Onset ChoreaAnthony E Lang, Emily Forbes, Pavan A Vaswani, et al.
NPJ Parkinson'S Disease|April 28, 2022
Gait abnormalities and non-motor symptoms predict abnormal dopaminergic imaging in presumed drug-induced ParkinsonismWhitley W Aamodt, Jacob G Dubroff, Gang Cheng, et al.
Movement Disorders Clinical Practice|October 27, 2018
Memantine and Cognition in Parkinson's Disease Dementia/Dementia With Lewy Bodies: A Meta-AnalysisLaura Brennan, Alexander Pantelyat, John E Duda, et al.
Neurology|November 16, 2012
Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson diseaseJoshua M Milber, Joseph V Noorigian, James F Morley, et al.
Neurology. Clinical Practice|June 28, 2016
High patient satisfaction with telehealth in Parkinson disease: A randomized controlled studyJayne R Wilkinson, Meredith Spindler, Stephanie M Wood, et al.
Archives of Rehabilitation Research and Clinical Translation|March 27, 2023
Deploying Digital Health Technologies for Remote Physical Activity Monitoring of Rural Populations With Chronic Neurologic DiseaseKimberly J Waddell, Mitesh S Patel, Jayne R Wilkinson, et al.
Pageof 6